Please see the NHS Surrey Nebulised Treatment Pathway attached below.



Similar documents
COPD - Education for Patients and Carers Integrated Care Pathway

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Patient Electronic Alert to Key-worker System (PEAKS) Guidelines

Consultation: Two proposals for registered nurse prescribing

National Institute for Health and Care Excellence. NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis

PSYCHOLOGICAL SERVICES TO RESPIRATORY MEDICINE 2011 ANNUAL REPORT EXECUTIVE SUMMARY

Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15

Deaths from Respiratory Diseases: Implications for end of life care in England. June

Applicant Information Sheet for MASS 45 Adult Oxygen: Initial Application and 4 Month Review

Medicines reconciliation on admission and discharge from hospital policy April WHSCT medicines reconciliation policy 1

Adult Neuromuscular pathway (Dec 2014) (18 years onwards)

frequently asked questions

Specialist Children s Service

Discharge Information Information for patients This leaflet is intended to help you, your carer, relatives and friends understand and prepare for

Pulmonary Rehabilitation in Newark and Sherwood

Sandwell Community Respiratory Service

MID STAFFORDSHIRE NHS FOUNDATION TRUST

Humulin R (U500) insulin: Prescribing Guidance

Managing the boundaries of NHS and privately funded healthcare Policy on the separation of private and NHS treatments

3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients

Adult Home Oxygen Therapy. Purpose To provide guidance on the requirements for and procedures relating to domiciliary oxygen therapy.

COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways

DWP Medical (factual) Reports. xxxsepteaa3

Platinum Healthcare Plan Benefit comparison of Bronze, Silver, Gold & Platinum healthcare plans

understanding the professional guidelines

National Clinical Programmes

Commissioning Policy (EMSCGP005V2) Defining the boundaries between NHS and Private Healthcare

H3 Insurance Cover for your business

Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD)

Mental Health Acute Inpatient Service Users Survey Questionnaire

Integrated Care Pathway

How To Provide Community Detoxification

Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group

Measuring quality along care pathways

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Defining the boundaries between NHS and Private Healthcare

Danbury Public Schools 63 Beaver Brook Rd. Danbury, CT Family Member s Name (if different from employee):

Who we are and what we do

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)

Chronic obstructive pulmonary disease (COPD)

(Completion rate: 72.73%) (Completed responses)

Consultation: Two proposals for registered nurse prescribing

Community Multiple Sclerosis Team Patient Information Leaflet

Consultation: Two proposals for registered nurse prescribing

Appendix 3 INDIVIDUAL PATIENT DRUG TREATMENT. POLICY AND PROCESS FOR DECISION MAKING September 2007

Measure Information Form (MIF) #275, adapted for quality measurement in Medicare Accountable Care Organizations

Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy

Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group

Everyone counts Ambitions for GCCG for 7 key outcome measures

THE ACQUIRED BRAIN INJURY STRATEGY FOR GRAMPIAN.

Pathway for Diagnosing COPD

Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance

APPENDIX 3 SERVICES LINKED WITH DUAL DIAGNOSIS TEAM

NEW RESPIRATORY HEALTH PROGRAM

RESPIRATORY NURSE SPECIALIST. Team M. Bowden, Helen Ogden, Janet Gill, Chris Hood, Debbie Tuck

Caring for the Dying Patient (CDP) Document

Medicare C/D Medical Coverage Policy

Service delivery interventions

Bupa Eduhealth Essentials Healthcare Scheme Bupa private medical cover for the teaching profession and education sector

Radiotherapy for a mesothelioma

2013/14 Choice Framework

University College London Hospitals. Psychological support services for people affected by cancer

Post discharge tariffs in the English NHS

Alternatives to Hospital: Models of Integrated Care

Salisbury Lung Cancer Service (1 of 5)

Guildford and Waverley Programme NHS Surrey Board 4 August 2009

Donepezil (Aricept ), Galantamine (Reminyl XL ), Rivastigmine (Exelon ) and Memantine (Ebixa )

Patient Sticker Multiple Sclerosis Ambulatory Emergency Care Pathway

Hospital ID: SS ID: NHS No: NI No: Surname: Forename: D.O.B:

Palliative Care The Relief You Need When You re Experiencing the Symptoms of Serious Illness

COMBINED PREDICTIVE MODEL FINAL REPORT

Consultation: Two proposals for registered nurse prescribing

Respiratory Care. A Life and Breath Career for You!

Shared Care Guideline-Use of Donepezil, Galantamine, Rivastigmine and Memantine in Dementia

Palliative Care Team King s College Hospital

Success and Survival in Pulmonary Rehab

Defining the boundaries between NHS and Private Healthcare

B Y N E R I T A C H A N, S P T, T M H O L I V I A F A N, P T I, U C H

Time to Act Urgent Care and A&E: the patient perspective

EUROPEAN LUNG FOUNDATION

When a Patient Dies Dr John Potter

Consultation: Two proposals for registered nurse prescribing

Rehabilitation Services within Essex Cancer Network for people with Brain & CNS tumours

Policy Document Control Page. Title: Protocol for Mental Health Inpatient Service Users who require care in the Pennine Acute Hospital

Consultation: Two proposals for registered nurse prescribing

Medicines Use Review Supporting Information for Asthma Patients

Guildford Dementia Information Prescription

Breakfast symposium: From hospital to home - the focus on the patient

Pulmonary Rehabilitation. Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Center Seattle, Washington 10/13/07

An Outcomes Strategy for COPD and Asthma: NHS Companion Document

Patient Access Policy

Priority Health. Priority Health and Priority Health 6 Summary. October Page 3

Guidance on competencies for management of Cancer Pain in adults

Identifying people with learning disabilities

Chronic Obstructive Pulmonary Disease Patient Guidebook

Understanding the role

Consultation: Two proposals for registered nurse prescribing

PATIENT ACCESS POLICY V3

Transcription:

Surrey Primary Care Trust Cedar Court Guildford Road Leatherhead KT22 9AE Tel: 01372 201700 Fax: 01372 201706 www.surreyhealth.nhs.uk November 11 th 2010 To: NHS Surrey GP s and Walk in Centre staff Re: Initiation of nebulised therapy Working together with Surrey respiratory care teams, NHS Surrey has recently funded and implemented a scheme to provide nebuliser machines to the following patients following formal assessment by a respiratory care team: COPD patients with distressing or disabling breathlessness despite maximal therapy using inhalers Bronchiectasis patients requiring nebulised antibiotics (based on sputum culture) / hypertonic saline Palliative Care/ Lung Cancer where nebulised therapy is thought to be required for more than a 2 month period (for shorter term use, patients would usually be loaned a machine by their palliative care team). Please see the NHS Surrey Nebulised Treatment Pathway attached below. The aim of this scheme is to support the implementation of a structured, evidence based, quality, cost effective model for the issue and community use of compressors and nebulised therapy for the relevant population within NHS Surrey. While day-to-day practice shows that nebulisers are used more widely, in fact, there is relatively limited evidence comparing the use of home nebulisers versus other modes of drug delivery. In asthma, nebulisers are only recommended in the treatment of severe acute asthma but not for chronic asthma. There is limited evidence supporting the use of home nebulisers in COPD, cystic fibrosis and HIV/AIDS. Nebulisers should not be seen as an easy alternative for those few patients unable to acquire and/or retain adequate inhaler technique. Nebuliser loading and operation requires manipulative and cognitive skill, and if lack of such skill is responsible for inadequate technique with inhaler devices it is likely that this may also be the case with a nebuliser.

We would therefore ask you not to initiate nebulised therapy in these patient groups without first referring the patient to either a respiratory care team or a palliative care team (for lung cancer/ palliative care patients) by completing Part 1 of the referral form (Appendix 1.) attached below. If you have any further queries, please do not hesitate to contact the team by emailing surreypct.oxygen@nhs.net Yours sincerely Linda Honey Head of Pharmaceutical Commissioning, NHS Surrey

NHS Surrey Nebulised treatment pathway

Patient with need for nebulised antibiotics demonstrated by sputum culture Patient meets criteria for home nebuliser use: distressing or disabling breathlessness despite maximal therapy using inhalers (including handheld device/technique and dosage optimisation and non-pharmacological techniques) Referral to respiratory consultant/ specialist nurse/ respiratory care team using referral form (Appendix 1) Patient education session on use of equipment. Written instructions/ disclaimer provided and signed by clinician/patient Organise loan of equipment including consumables via Respiratory Care Team at local site Patient is assessed at 2 weeks by RCT for review of effectiveness of nebulised therapy and need for continuation Home nebuliser no longer required: loaned equipment returned to RCT Returned loan-equipment decontaminated by respiratory care team Home nebuliser is effective loaned equipment returned and patient s own nebuliser ordered from & delivered by Phillips Respironics Prescription of nebulised medicines taken over by GP Appendix 1 (and 2 if continuation of nebuliser) faxed to NHS Surrey by respiratory care team Annual assessment/follow-up by respiratory care team Faulty equipment or replacement required: patient contacts Phillips Respironics help-line in the first instance, then if required replacement equipment will be arranged. *All compressors remain the property of Phillips Respironics

Appendix 1. Standard Referral/Issue form for Home Nebulisers to used by adult respiratory patients in Surrey PCT Part 1: To be completed by referrer (hospital clinician / GP): Name: Designation: Contact Number: Date of referral: Patient Name: Patient Address: Hospital Number: NHS Number: D.O.B.: Outpatient Inpatient GP referral (Please tick) If inpatient: Ward: Hospital: Ward phone number: Do they meet the following criteria? (please tick) New patient requiring nebulised therapy: Yes No 1. Confirmed diagnosis of severe COPD Bronchiectasis requiring nebulised therapy Palliative care / lung cancer 2. Distressing or disabling breathlessness despite maximal therapy using inhalers (including hand-held device/technique and dosage optimisation and non-pharmacological measures such as breathlessness and anxiety management, chest clearance) Need for nebulised antibiotics demonstrated by sputum culture This is for a patient already receiving nebulised therapy who: 1. Has a machine which is no longer functioning and cannot be repaired under the existing service agreement or has outlived its pre-determined life-span requires replacement. 2. Has been re-assessed for continuing requirement of nebulised therapy. For all patients: 3. Has a full explanation/education package been given to the patient/carer? 4. Has the patient s/carer s ability to use the nebuliser been assessed?

If the answer to any of these questions is no and home nebuliser therapy is considered appropriate the request must come from a respiratory consultant with the rationale for a home nebuliser documented below: Once completed send referral form to the respiratory care team: Fax no of team Form reviewed by: Designation: Respiratory Care Team: Date and place compressor & consumables loaned if appropriate: Part 2. Continuing on nebulised therapy after a two week trial period and requiring their own machine Do they meet the following criteria? (please tick) 1.Response to nebulised bronchodilators has been objectively assessed by the Respiratory Care Team as per Appendix 4 (for patients on nebulised bronchodilators only) 2. Patient demonstrated beneficial response to nebulised treatment and is considered appropriate for on going treatment (for patients on all nebulised therapies) Yes No Assessment completed by: Designation: Respiratory Care Team: Phone number: Date of assessment: I give consent for the information in Appendices 1&2 to be passed onto NHS Surrey so that funding and delivery of the compressor can be arranged. Patient Signature: Date:

Appendix 1. and Compressor issue/ consumable order form (Appendix 2) completed and faxed to NHS Surrey: (01372 209 361) (please tick)